Literature DB >> 26647618

METABOLOMICS IN MEDICAL SCIENCES--TRENDS, CHALLENGES AND PERSPECTIVES.

Agnieszka Klupczyńska, Paweł Dereziński, Zenon J Kokot.   

Abstract

Metabolomics is the latest of the "omic" technologies that involves comprehensive analysis of small molecule metabolites of an organism or a specific biological sample. Metabolomics provides an insight into the cell status and describes an actual health condition of organisms. Analysis of metabolome offers a unique opportunity to study the influence of genetic variation, disease, applied treatment or diet on endogenous metabolic state of organisms. There are many areas that might benefit from metabolomic research. In the article some applications of this novel "omic" technology in the field of medical sciences are presented. One of the most popular aims of metabolomic studies is biomarker discovery. Despite using the state-of-art analytical techniques along with advanced bioinformatic tools, metabolomic experiments encounter numerous difficulties and pitfalls. Challenges that researchers in the field of analysis of metabolome have to face include i.a., technical limitations, bioinformatic challenges and integration with other "omic" sciences. One of the grand challenges for studies in the field of metabolomics is to tackle the problem of data analysis, which is probably the most time consuming stage of metabolomic workflow and requires close collaboration between analysts, clinicians and experts in chemometric analysis. Implementation of metabolomics into clinical practice will be dependent on establishment of standardized protocols in analytical performance and data analysis and development of fit-for-purpose biomarker method validation. Metabolomics allows to achieve a sophisticated level of information about biological systems and opens up new perspectives in many fields of medicine, especially in oncology. Apart from its extensive cognitive significance, metabolomics manifests also a practical importance as it may lead to design of new non-invasive, sensitive and specific diagnostic techniques and development of new therapies.

Mesh:

Substances:

Year:  2015        PMID: 26647618

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  31 in total

1.  Opportunities and Limitations for Untargeted Mass Spectrometry Metabolomics to Identify Biologically Active Constituents in Complex Natural Product Mixtures.

Authors:  Lindsay K Caesar; Joshua J Kellogg; Olav M Kvalheim; Nadja B Cech
Journal:  J Nat Prod       Date:  2019-03-07       Impact factor: 4.050

2.  Hierarchical cluster analysis of technical replicates to identify interferents in untargeted mass spectrometry metabolomics.

Authors:  Lindsay K Caesar; Olav M Kvalheim; Nadja B Cech
Journal:  Anal Chim Acta       Date:  2018-03-19       Impact factor: 6.558

3.  UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.

Authors:  Yang Wang; Cong-Hui Wang; Yu-Fei Zhang; Liang Zhu; Hui-Min Lei; Ya-Bin Tang
Journal:  Metabolomics       Date:  2019-03-25       Impact factor: 4.290

Review 4.  Metabolomics as a valid analytical technique in environmental exposure research: application and progress.

Authors:  Shuang Wei; Yuanyun Wei; Yaqi Gong; Yonglin Chen; Jian Cui; Linwei Li; Hongxia Yan; Yueqiu Yu; Xiang Lin; Guoqing Li; Lan Yi
Journal:  Metabolomics       Date:  2022-05-31       Impact factor: 4.290

5.  Best Practices for Preparation of Staphylococcus aureus Metabolomics Samples.

Authors:  Kimberly L James; Kelly C Rice
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Noninvasive metabolic profiling for painless diagnosis of human diseases and disorders.

Authors:  Mainak Mal
Journal:  Future Sci OA       Date:  2016-06-10

7.  Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder.

Authors:  Hidehiro Umehara; Shusuke Numata; Shin-Ya Watanabe; Yutaka Hatakeyama; Makoto Kinoshita; Yukiko Tomioka; Kiyoshi Nakahara; Takeshi Nikawa; Tetsuro Ohmori
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

8.  Progress in Metabolomics Standardisation and its Significance in Future Clinical Laboratory Medicine.

Authors:  Daniel A Dias; Therese Koal
Journal:  EJIFCC       Date:  2016-12-01

9.  Impact of Pre-blood Collection Factors on Plasma Metabolomic Profiles.

Authors:  Sheetal Hardikar; Richard D Albrechtsen; David Achaintre; Tengda Lin; Svenja Pauleck; Mary Playdon; Andreana N Holowatyj; Biljana Gigic; Petra Schrotz-King; Juergen Boehm; Nina Habermann; Stefanie Brezina; Andrea Gsur; Eline H van Roekel; Matty P Weijenberg; Pekka Keski-Rahkonen; Augustin Scalbert; Jennifer Ose; Cornelia M Ulrich
Journal:  Metabolites       Date:  2020-05-21

10.  Cigarette smoking is associated with an altered vaginal tract metabolomic profile.

Authors:  T M Nelson; J C Borgogna; R D Michalek; D W Roberts; J M Rath; E D Glover; J Ravel; M D Shardell; C J Yeoman; R M Brotman
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.